Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2026)

Catalyst Pharmaceuticals' (CPRX) quarterly Asset Utilization Ratio came in at 0.53 in Q1 2026, down 12.71% YoY from 0.61 in Q1 2025, and down 2.97% on a QoQ basis from 0.55 in Q4 2025.

Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Catalyst Pharmaceuticals (CPRX) has 9 years of Asset Utilization Ratio data on file, last reported at 0.53 in Q1 2026.

  • Quarterly Asset Utilization Ratio fell 12.71% year-over-year to 0.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.53 (down 12.71% YoY) and the FY2025 annual result came in at 0.6, down 19.05% from the prior year.
  • Asset Utilization Ratio retreated to 0.53 in Q1 2026, from 0.55 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.9 in Q4 2023 to a low of 0.53 in Q1 2026.
  • A 5-year average of 0.65 and a median of 0.63 in 2022 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 49.16% — and 2024, when it sank 32.81%.
  • Tracing CPRX's Asset Utilization Ratio over 5 years: stood at 0.6 in 2022, then surged by 49.16% to 0.9 in 2023, then slumped by 32.81% to 0.61 in 2024, then declined by 9.79% to 0.55 in 2025, then decreased by 2.97% to 0.53 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.53 (Q1 2026), 0.55 (Q4 2025), and 0.57 (Q3 2025), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.38
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.69
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 186.67
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.13
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.90
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.54
10 Catalyst Pharmaceuticals 3.85 Bn 3.09 Bn 134.92 Mn 0.53

Historic Data

Download Data
DateValue
Mar 31, 2026 0.53
Dec 31, 2025 0.55
Sep 30, 2025 0.57
Jun 30, 2025 0.59
Mar 31, 2025 0.61
Dec 31, 2024 0.61
Sep 30, 2024 0.62
Jun 30, 2024 0.64
Mar 31, 2024 0.74
Dec 31, 2023 0.90
Sep 30, 2023 0.81
Jun 30, 2023 0.71
Mar 31, 2023 0.66
Dec 31, 2022 0.60
Sep 30, 2022 0.64
Jun 30, 2022 0.66
Mar 31, 2022 0.63
Dec 31, 2021 0.61
Sep 30, 2021 0.62
Jun 30, 2021 0.62